Procyon Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-930
Closed -$238K 604
2025
Q4
$238K Sell
930
-92
-9% -$24.1K 0.01% 491
2025
Q3
$266K Buy
1,022
+92
+10% +$24.2K 0.02% 424
2025
Q2
$227K Buy
+930
New +$232K 0.02% 430
2024
Q1
Sell
-499
Closed -$228K 525
2023
Q4
$228K Sell
499
-204
-29% -$101K 0.02% 465
2023
Q3
$342K Buy
703
+158
+29% +$74.3K 0.04% 367
2023
Q2
$244K Buy
+545
New +$274K 0.03% 394
2020
Q3
Sell
-289
Closed -$112K 566
2020
Q2
$112K Sell
289
-1
-0.3% -$374 0.06% 273
2020
Q1
$91K Sell
290
-19
-6% -$6.41K 0.06% 255
2019
Q4
$113K Buy
+309
New +$98K 0.07% 249

Other funds holding HUM

Procyon Advisors's HUM Position: Q1 2026 in Review

Procyon Advisors sold out of Humana (HUM) in Q1 2026, closing a stake of 930 shares — an estimated $238K sold.

Procyon Advisors first reported a position in HUM in Q4 2019 and held it in 9 quarters. The position peaked at $342K in Q3 2023. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Procyon Advisors reported no remaining Humana position as of Q1 2026 after selling out during the quarter.
  • Procyon Advisors sold 930 Humana shares in Q1 2026, an estimated $238K.
  • Procyon Advisors first reported a position in Humana in Q4 2019 and held it in 9 quarters.
  • Procyon Advisors's Humana position peaked at $342K in Q3 2023.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Procyon Advisors's 13F filing for Q1 2026, filed 4 May 2026.